Cinira Lefèvre

482 total citations
23 papers, 358 citations indexed

About

Cinira Lefèvre is a scholar working on Cardiology and Cardiovascular Medicine, Internal Medicine and Epidemiology. According to data from OpenAlex, Cinira Lefèvre has authored 23 papers receiving a total of 358 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Cardiology and Cardiovascular Medicine, 8 papers in Internal Medicine and 6 papers in Epidemiology. Recurrent topics in Cinira Lefèvre's work include Atrial Fibrillation Management and Outcomes (14 papers), Venous Thromboembolism Diagnosis and Management (8 papers) and Cardiac Arrhythmias and Treatments (6 papers). Cinira Lefèvre is often cited by papers focused on Atrial Fibrillation Management and Outcomes (14 papers), Venous Thromboembolism Diagnosis and Management (8 papers) and Cardiac Arrhythmias and Treatments (6 papers). Cinira Lefèvre collaborates with scholars based in France, United Kingdom and Spain. Cinira Lefèvre's co-authors include David Evans, Michelle Johnson, Andrew Maguire, Morten Lamberts, Gunnar Gislason, Emil Loldrup Fosbøl, Laila Stærk, Jonas Bjerring Olesen, Morten Lock Hansen and Éric Van Ganse and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of the American College of Cardiology and PLoS ONE.

In The Last Decade

Cinira Lefèvre

21 papers receiving 354 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Cinira Lefèvre France 9 284 122 63 38 34 23 358
Youngsook Choi United States 7 195 0.7× 91 0.7× 46 0.7× 16 0.4× 16 0.5× 16 279
Sharon Crugnale United States 6 423 1.5× 204 1.7× 54 0.9× 23 0.6× 5 0.1× 8 457
Tiffany Hu United States 8 192 0.7× 55 0.5× 59 0.9× 12 0.3× 8 0.2× 21 287
Rossella Morandini Italy 6 241 0.8× 176 1.4× 33 0.5× 9 0.2× 5 0.1× 9 389
Euan McLeod United Kingdom 9 70 0.2× 45 0.4× 62 1.0× 43 1.1× 29 0.9× 14 194
I Montserrat Spain 6 130 0.5× 66 0.5× 33 0.5× 15 0.4× 5 0.1× 13 268
Alan John Camm United Kingdom 10 629 2.2× 155 1.3× 73 1.2× 60 1.6× 2 0.1× 15 670
Steve Deitelzweig United States 10 456 1.6× 250 2.0× 70 1.1× 77 2.0× 22 494
Jeff Taylor United States 5 239 0.8× 178 1.5× 33 0.5× 6 0.2× 2 0.1× 5 325
Martin E W Hemels Netherlands 12 435 1.5× 110 0.9× 48 0.8× 53 1.4× 1 0.0× 63 484

Countries citing papers authored by Cinira Lefèvre

Since Specialization
Citations

This map shows the geographic impact of Cinira Lefèvre's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cinira Lefèvre with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cinira Lefèvre more than expected).

Fields of papers citing papers by Cinira Lefèvre

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cinira Lefèvre. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cinira Lefèvre. The network helps show where Cinira Lefèvre may publish in the future.

Co-authorship network of co-authors of Cinira Lefèvre

This figure shows the co-authorship network connecting the top 25 collaborators of Cinira Lefèvre. A scholar is included among the top collaborators of Cinira Lefèvre based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cinira Lefèvre. Cinira Lefèvre is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Borget, Isabelle, G. Lefèvre, Cinira Lefèvre, et al.. (2022). POSA387 Healthcare Resource Utilization and Direct Medical Costs in French Patients Receiving Treatment for Hypogammaglobulinemia: A National Cohort Study. Value in Health. 25(1). S248–S249. 1 indexed citations
2.
Lefèvre, Cinira, et al.. (2022). RWD54 Healthcare Resource Use and Associated Costs of Congenital Thrombotic Thrombocytopenic Purpura in France. Value in Health. 25(12). S458–S459.
3.
Ganse, Éric Van, Nicolas Danchin, Isabelle Mahé, et al.. (2020). Comparative Safety and Effectiveness of Oral Anticoagulants in Nonvalvular Atrial Fibrillation. Stroke. 51(7). 2066–2075. 47 indexed citations
4.
Alikhan, Raza, Cinira Lefèvre, Ian Menown, et al.. (2019). Risk of Recurrent Bleeding Events in Nonvalvular Atrial Fibrillation Treated with Vitamin K Antagonists: A Clinical Practice Research Datalink Study. SHILAP Revista de lepidopterología. 3(4). e316–e324. 3 indexed citations
5.
Johnson, Michelle, Cinira Lefèvre, Andrew Maguire, et al.. (2018). Initiation and continuation of oral anticoagulant prescriptions for stroke prevention in non-valvular atrial fibrillation: A cohort study in primary care in France. Archives of cardiovascular diseases. 111(5). 370–379. 14 indexed citations
6.
Lumley, Matthew, Laura McDonald, Sreeram V Ramagopalan, et al.. (2017). Evolving landscape of stroke prevention in atrial fibrillation within the UK between 2012 and 2016: a cross-sectional analysis study using CPRD. BMJ Open. 7(9). e015363–e015363. 30 indexed citations
7.
8.
Lefèvre, Cinira, et al.. (2017). Oral anticoagulant persistence in patients with non-valvular atrial fibrillation: A cohort study using primary care data in Germany. PLoS ONE. 12(10). e0185642–e0185642. 27 indexed citations
9.
Sangiorgi, Diego, Valentina Perrone, Stefano Buda, et al.. (2017). Epidemiology, patient profile, and health care resource use for hepatitis C in Italy. ClinicoEconomics and Outcomes Research. Volume 9. 609–616. 6 indexed citations
10.
Young, Jim, Nina Weis, Harald Hofer, et al.. (2017). The effectiveness of daclatasvir based therapy in European patients with chronic hepatitis C and advanced liver disease. BMC Infectious Diseases. 17(1). 45–45. 13 indexed citations
11.
Lamberts, Morten, Laila Stærk, Jonas Bjerring Olesen, et al.. (2017). Major Bleeding Complications and Persistence With Oral Anticoagulation in Non‐Valvular Atrial Fibrillation: Contemporary Findings in Real‐Life Danish Patients. Journal of the American Heart Association. 6(2). 109 indexed citations
12.
Albertí, A., et al.. (2016). Literature review of the distribution of hepatitis C virus genotypes across Europe. Journal of Medical Virology. 88(12). 2157–2169. 20 indexed citations
13.
Lefèvre, Cinira, et al.. (2016). CHANGES OVER TIME IN TREATMENT PERSISTENCE OF ORAL ANTICOAGULANTS IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION. Journal of the American College of Cardiology. 67(13). 769–769. 3 indexed citations
14.
Lamberts, Morten, et al.. (2016). COMPARISON OF BLEEDING AND TREATMENT PERSISTENCE AMONG NEW USERS OF NOVEL ORAL ANTICOAGULANTS AND WARFARIN IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION. Journal of the American College of Cardiology. 67(13). 887–887. 2 indexed citations
15.
Blommestein, Hedwig M., et al.. (2016). Real-World Evidence on Healthcare Resource use and Associated Cost With Multiple Myeloma in The Netherlands. Value in Health. 19(7). A751–A751. 2 indexed citations
16.
Lefèvre, Cinira, et al.. (2016). COMPARISON OF TREATMENT PERSISTENCE IN THE REAL-WORLD USE OF NOVEL ORAL ANTICOAGULANTS AMONG PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION. Journal of the American College of Cardiology. 67(13). 792–792. 2 indexed citations
17.
18.
19.
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Youngsook Choi Breakdown of academic impact, for papers by Sharon Crugnale Breakdown of academic impact, for papers by Tiffany Hu Breakdown of academic impact, for papers by Rossella Morandini Breakdown of academic impact, for papers by Euan McLeod Breakdown of academic impact, for papers by I Montserrat Breakdown of academic impact, for papers by Alan John Camm Breakdown of academic impact, for papers by Steve Deitelzweig Breakdown of academic impact, for papers by Jeff Taylor Breakdown of academic impact, for papers by Martin E W Hemels
Rankless by CCL
2026